Ronnie Andrews, CEO, Oncocyte discusses the company's mission to answer critical questions along the cancer care continuum through the use of their molecular tests for diagnosis and treatment of early stage lung cancer. Ronnie also talks about the changes in cancer care over the past 20 years and the potential these tests have to positively impact patients in the future.
@oncocyteLBX
#moleculardiagnostics #lungcancer #liquidbiopsy #earlydetection
Oncocyte.com
Download the transcript here
